Blood thinners, a vital tool in preventing deadly clots, come with a dark side. They are a leading cause of drug-related harm, and the risks are often overlooked. Larry Bordeaux, a survivor, knows this all too well. His story is a cautionary tale, highlighting the delicate balance between life-saving medication and the potential for uncontrolled bleeding.
Bordeaux, like over 8 million others in the U.S., takes blood thinners. For him, it's a necessary evil. While these drugs have saved countless lives, they also carry a significant risk of unintended bleeding events. The numbers are staggering: hundreds of thousands of older adults are hospitalized annually due to these events, costing the healthcare system billions.
But here's where it gets controversial: despite the risks, blood thinners are widely prescribed. Many patients, like Bordeaux, develop clots post-surgery and are put on these medications. Others take them due to age-related heart rhythm disorders. The issue is, blood thinners interfere with the body's natural clotting process, and this can lead to serious bleeding complications.
Dr. Samin Sharma, a director at Mount Sinai Fuster Heart Hospital, puts it plainly: "While they prevent stroke and embolism, they do cause bleeding." Even President Trump, who takes aspirin daily, has mentioned the risks of bruising associated with blood thinners.
The most common issue is bleeding in the stomach and gastrointestinal tract, which can be very serious and even lead to death if not stabilized quickly. People on anticoagulants can also experience uncontrolled nosebleeds, blood in the urine, and in rare cases, brain hemorrhages or bleeding in the lungs.
So, why are these risks not more widely known? Advocates argue that patients and their families are not sufficiently informed. Leslie Lake, president of the National Blood Clot Alliance, says, "Bleeding events aren't rare edge cases; they happen every day." And research suggests that almost half of all adverse events related to these drugs could be avoided.
A new class of blood thinners, known as direct oral anticoagulants (DOACs), was supposed to be the solution. These drugs, including apixaban, dabigatran, edoxaban, and rivaroxaban, were shown to be safer and more consistent than warfarin, the previous drug of choice. However, a recent study found that the proportion of patients hospitalized on these newer drugs remains similar to that of warfarin.
Why is this the case? Part of the issue is that the new generation of blood thinners is sometimes prescribed without sufficient oversight. The risk of bleeds can be aggravated when blood thinners are prescribed for too long or when they are given alongside other anti-clotting medications, like antiplatelet drugs. Additionally, patients often take blood thinners alongside common anti-inflammatories like aspirin, further increasing the risk of bleeding.
Experts say that even with the newer generation of drugs, doctors need to be careful to prescribe the appropriate drug and dose. If the dose is too high or not adjusted over time, the risk of serious bleeding events increases. Weighing the risks is a delicate balance, and it's not always an easy choice for doctors.
Some hospitals are turning to predictive models and AI tools to help doctors make these decisions. Emerging technologies can identify the correct dose for patients and prioritize those who need specialist care. Additionally, experts are studying new treatment possibilities, such as ablation, which may offer a better long-term solution for certain conditions, reducing the need for blood thinners.
Finding ways to address patient harm linked to blood thinners is crucial. As Dr. Pieter Cohen, an associate professor at Harvard University, says, "We can really prevent a lot of GI bleeds, traumatic brain injuries, and emergency department visits if we get this under better control."
So, while blood thinners are a necessary tool in modern medicine, the risks must be carefully managed and communicated to patients. It's a delicate balance, but with better awareness and management, we can strive to prevent the adverse events that affect so many.
